Pharma Focus Europe on Feedspot

Nanoform and Plusvitech Partner to Repurpose Aprepitant as a Treatment for Lung Cancer

Pharma Focus Europe

by

6d ago

Nanoform Finland Plc the medicine performanceenhancing company today announced a collaboration with PlusVitech a biotechnology company developing treatments for cancer ..read more

Visit website

BrainStorm Cell Therapeutics Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Phase 3b Trial in ALS

Pharma Focus Europe

by

6d ago

BrainStorm Cell Therapeutics Inc a leading developer of adult stem cell therapeutics for neurodegenerative diseases today announced that it received ..read more

Visit website

AustinPx Boosts Drug Development Through Investments in Pharmaceutics and Manufacturing

Pharma Focus Europe

by

6d ago

AustinPx a prominent contract development and manufacturing organization specializing in enhancing the bioavailability of orally administered small molecule drug candidates has recently acquired advanced ..read more

Visit website

Vertex Enters Into Agreement to Acquire Alpine Immune Sciences

Pharma Focus Europe

by

6d ago

Vertex Pharmaceuticals Incorporated and Alpine Immune Sciences Inc a biotechnology company focused on discovering and developing innovative proteinbased immunotherapies today announced that the companies ..read more

Visit website

Vivet Therapeutics Administers First Patient Dose in Cohort 2 of Phase 1/2 GATEWAY Clinical Trial for Wilson Disease Treatment

Pharma Focus Europe

by

6d ago

Vivet Therapeutics has achieved a significant milestone in its effort to address Wilson Disease a rare inherited liver metabolic disorder characterized by the accumulation of toxic copper levels ..read more

Visit website

Shorla Oncology Receives FDA Acceptance for New Drug Application Targeting Specific Forms of Leukemia and Other Cancers

Pharma Focus Europe

by

6d ago

Shorla Oncology a specialty pharmaceutical company headquartered in both the United States and Ireland has made a significant announcement today The US Food and Drug Administration ..read more

Visit website

Model Medicines Announces Breakthroughs in AI-Driven Drug Discovery: Two New Preprint Papers Showcase Innovations in Novel Chemistry and Biology

Pharma Focus Europe

by

6d ago

Model Medicines a prominent company in the field of human health specializing in AIdriven drug discovery has released two significant preprint papers on bioRxiv outlining major advancements ..read more

Visit website

TR1X Receives FDA Approval for TRX103: Allogeneic Regulatory T-Cell Therapy Targeting Autoimmune Diseases

Pharma Focus Europe

by

6d ago

TrX Inc a company focusing on autoimmune and inflammatory disease treatments has received FDA approval for its Investigational New Drug application for TRX This drug aims to prevent Graft versus ..read more

Visit website

Candel Therapeutics Secures FDA Orphan Drug Designation for CAN-2409 Targeting Pancreatic Cancer

Pharma Focus Europe

by

6d ago

Candel Therapeutics Inc publicly traded under the symbol CADL on the Nasdaq has been granted Orphan Drug Designation by the US Food and Drug Administration for its leading candidate ..read more

Visit website

European Commission Approves Merck’s KEYTRUDA® Plus Chemotherapy for Resectable NSCLC

Pharma Focus Europe

by

2w ago

Merck known as MSD outside of the United States and Canada today announced that the European Commission has approved KEYTRUDA Mercks antiPD therapy in combination ..read more

Visit website

Follow Pharma Focus Europe on FeedSpot